Zantac Thyroid Cancer

Zantac has been pulled from the shelves after a recent Food and Drug Administration (FDA) market withdrawal. A contaminate known as NDMA (N-Nitrosodimethylamine) was discovered in Zantac and other ranitidine products, and the implications are serious. The World Health Organization (WHO), the Environmental Protection Agency (EPA), and various other important national and international health organizations all deem NDMA a probable carcinogen (cancer-causing agent). Thyroid cancer is one form of cancer associated with Zantac and similar generic medications.

Thyroid Cancer

The Mayo Clinic reports that thyroid cancer grows in the thyroid, which regulates our heart rate, blood pressure, weight, and body temperature. Some forms of thyroid cancer can be slow growing while others can be very aggressive. Further, thyroid cancer appears to be on the rise. Thyroid cancer is often slow to present with symptoms, which can make early diagnosis elusive. Nevertheless, there are symptoms that are closely associated with thyroid cancer as it continues to progress, including:

• A lump in the neck that can be felt through the skin
• Difficulties with swallowing
• Changes in one’s voice, such as hoarseness that continues to increase
• Swollen lymph nodes in one’s neck
• Pain in one’s throat and/or neck

If you have any of these symptoms or any other related physical concerns, seek medical attention.

Work Closely with an Experienced Drug Injury Attorney

If you used Zantac regularly and have since been diagnosed with thyroid cancer, you may have legal recourse. A dedicated drug injury attorney will skillfully advocate for the compensation to which you are entitled.